Office of Dietary Supplements VDSP Commutability Study 2, 17441 [2015-07326]

Download as PDF Federal Register / Vol. 80, No. 62 / Wednesday, April 1, 2015 / Notices napa@hhs.gov and put ‘‘April 28 Meeting Attendance’’ in the Subject line by Friday, April 17, so that their names may be put on a list of expected attendees and forwarded to the security officers at the Department of Health and Human Services. Any interested member of the public who is a non-U.S. citizen should include this information at the time of registration to ensure that the appropriate security procedure to gain entry to the building is carried out. Although the meeting is open to the public, procedures governing security and the entrance to Federal buildings may change without notice. If you wish to make a public comment, you must note that within your email. SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)). Topics of the Meeting: The Advisory Council will hear presentations on the basics of long-term care, including presentations on programs, settings, and payers. The Council will use a portion of the meeting to review the work it has accomplished thus far towards the 2025 goals, and then discuss the process for developing recommendations for the 2015 update to the National Plan. The Council will also hear presentations from the three subcommittees (Research, Clinical Care, Long-Term Services and Supports, and Ethics). Procedure and Agenda: This meeting is open to the public. Please allow 30 minutes to go through security and walk to the meeting room. The meeting will also be webcast at www.hhs.gov/live. Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National Alzheimer’s Project Act. The panel is governed by provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. Vitamin D External Quality Assessment Scheme (DEQAS), announce that as part of the Vitamin D Standardization Program (VDSP), they are recruiting laboratories to participate in a study of the commutability of pooled serum samples used in assays to measure total 25-hydroxyvitamin D [25(OH)D]. DATES: The expected start date for the study is June 2015. ADDRESSES: For more information about the study and to let us know if you are interested in participating, please contact us at: vdsp@mail.nih.gov. FOR FURTHER INFORMATION CONTACT: Drs. Johanna Camara, NIST, and Christopher Sempos, ODS, Director and Co-Director, respectively, for the VDSP Commutability Study 2. Email: VDSP@ mail.nih.gov. SUPPLEMENTARY INFORMATION: The objective of the study is to promote the standardized measurement of total 25(OH)D by evaluating the commutability of NIST Standard Reference Materials® (SRM) used as ‘‘trueness’’ controls and the materials used in the major Performance Testing/ External Quality (PT/EQA) programs administered by CAP and DEQAS. Who Can Participate: (1) All commercial manufacturers of 25(OH)D assays (requests from manufacturers with assays in development will be considered); (2) Clinical and research laboratories using a commercial assay platform; (3) Laboratories for national/ subnational nutrition surveys; and (4) Laboratories using in-house developed assays. For details about the study design and time lines, see the recently published paper in the February 2015 edition of Clinical Laboratory News, (https:// www.aacc.org/publications/cln/articles/ 2015/february/vitamin-dcommutability-study). Dated: March 25, 2015. Richard G. Frank, Assistant Secretary for Planning and Evaluation. Dated: March 24, 2015. Lawrence A. Tabak, Deputy Director, National Institutes of Health. [FR Doc. 2015–07374 Filed 3–31–15; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2015–07326 Filed 3–31–15; 8:45 am] BILLING CODE 4150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSK4VPTVN1PROD with NOTICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Office of Dietary Supplements VDSP Commutability Study 2 NIH Office of Dietary Supplements (ODS) and the National Institute of Standards and Technology (NIST), in collaboration with the College of American Pathologists (CAP) and SUMMARY: VerDate Sep<11>2014 18:37 Mar 31, 2015 Jkt 235001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 17441 provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Fibroblast Growth Factor And Aging. Date: May 1, 2015. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, Suite 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Alicja L. Markowska, Ph.D., DSC., Scientific Review Branch, National Institute On Aging, 7201 Wisconsin Avenue, Suite 2c212, Bethesda, MD 20892, 301–496–9666, markowsa@nia.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: March 26, 2015. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–07338 Filed 3–31–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Board of Scientific Counselors, NIA. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the NATIONAL INSTITUTE ON AGING, including consideration of personnel qualifications and performance, and the E:\FR\FM\01APN1.SGM 01APN1

Agencies

[Federal Register Volume 80, Number 62 (Wednesday, April 1, 2015)]
[Notices]
[Page 17441]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-07326]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Dietary Supplements VDSP Commutability Study 2

SUMMARY: NIH Office of Dietary Supplements (ODS) and the National 
Institute of Standards and Technology (NIST), in collaboration with the 
College of American Pathologists (CAP) and Vitamin D External Quality 
Assessment Scheme (DEQAS), announce that as part of the Vitamin D 
Standardization Program (VDSP), they are recruiting laboratories to 
participate in a study of the commutability of pooled serum samples 
used in assays to measure total 25-hydroxyvitamin D [25(OH)D].

DATES: The expected start date for the study is June 2015.

ADDRESSES: For more information about the study and to let us know if 
you are interested in participating, please contact us at: 
vdsp@mail.nih.gov.

FOR FURTHER INFORMATION CONTACT: Drs. Johanna Camara, NIST, and 
Christopher Sempos, ODS, Director and Co-Director, respectively, for 
the VDSP Commutability Study 2. Email: VDSP@mail.nih.gov.

SUPPLEMENTARY INFORMATION: The objective of the study is to promote the 
standardized measurement of total 25(OH)D by evaluating the 
commutability of NIST Standard Reference Materials[supreg] (SRM) used 
as ``trueness'' controls and the materials used in the major 
Performance Testing/External Quality (PT/EQA) programs administered by 
CAP and DEQAS. Who Can Participate: (1) All commercial manufacturers of 
25(OH)D assays (requests from manufacturers with assays in development 
will be considered); (2) Clinical and research laboratories using a 
commercial assay platform; (3) Laboratories for national/subnational 
nutrition surveys; and (4) Laboratories using in-house developed 
assays.
    For details about the study design and time lines, see the recently 
published paper in the February 2015 edition of Clinical Laboratory 
News, (https://www.aacc.org/publications/cln/articles/2015/february/vitamin-d-commutability-study).

    Dated: March 24, 2015.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2015-07326 Filed 3-31-15; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.